Merkliste 
 1 Ergebnisse 
 
1

Subcutaneous Ocrelizumab in Patients with Multiple Sclerosi..:

Newsome, SD ; Krzystanek, E ; Selmaj, K...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105307 , 2023